ES549359A0 - Un procedimiento para la preparacion de nuevos derivados del acido (5-amino-2-hidroxi)benzoico. - Google Patents

Un procedimiento para la preparacion de nuevos derivados del acido (5-amino-2-hidroxi)benzoico.

Info

Publication number
ES549359A0
ES549359A0 ES549359A ES549359A ES549359A0 ES 549359 A0 ES549359 A0 ES 549359A0 ES 549359 A ES549359 A ES 549359A ES 549359 A ES549359 A ES 549359A ES 549359 A0 ES549359 A0 ES 549359A0
Authority
ES
Spain
Prior art keywords
benzoic
hydroxy
amino
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES549359A
Other languages
English (en)
Other versions
ES8701717A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Italfarmaco SpA
Original Assignee
Italfarmaco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco SpA filed Critical Italfarmaco SpA
Publication of ES549359A0 publication Critical patent/ES549359A0/es
Publication of ES8701717A1 publication Critical patent/ES8701717A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES549359A 1984-11-29 1985-11-28 Un procedimiento para la preparacion de nuevos derivados del acido (5-amino-2-hidroxi)benzoico. Expired ES8701717A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23799/84A IT1196348B (it) 1984-11-29 1984-11-29 Composti ad attivita'antiinfiammatoria

Publications (2)

Publication Number Publication Date
ES549359A0 true ES549359A0 (es) 1986-12-01
ES8701717A1 ES8701717A1 (es) 1986-12-01

Family

ID=11210091

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549359A Expired ES8701717A1 (es) 1984-11-29 1985-11-28 Un procedimiento para la preparacion de nuevos derivados del acido (5-amino-2-hidroxi)benzoico.

Country Status (12)

Country Link
EP (1) EP0236329A1 (es)
JP (1) JPS62501703A (es)
KR (1) KR870700608A (es)
CN (1) CN85109554A (es)
AU (1) AU5231186A (es)
DK (1) DK346486A (es)
ES (1) ES8701717A1 (es)
GR (1) GR852834B (es)
IT (1) IT1196348B (es)
PT (1) PT81566B (es)
WO (1) WO1986003199A1 (es)
ZA (1) ZA859035B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9017710D0 (en) * 1990-08-13 1990-09-26 May & Baker Ltd New compositions of matter
GB9017711D0 (en) * 1990-08-13 1990-09-26 May & Baker Ltd New compositions of matter
IT1244873B (it) * 1990-09-12 1994-09-12 Depha Team Srl Derivati dell'acido 5-aminosalicilico (5-asa) per la terapia delle infiammazioni croniche intestinali
US5366987A (en) * 1991-08-22 1994-11-22 Warner-Lambert Company Isoxazolyl-substituted alkyl amide ACAT inhibitors
FR2738150B1 (fr) * 1995-09-01 1997-10-31 Synthelabo Utilisation de la sulphasalazine et de ses metabolites pour la fabrication d'un medicament utile dans le traitement de l'insuffisance veineuse et des ulceres veineux
AU2000241494B2 (en) * 2000-04-19 2005-03-17 Gnt Pharma Co., Ltd. Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
US6964982B2 (en) 2000-04-20 2005-11-15 Neurotech Co., Ltd. Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
DE60114724T2 (de) * 2000-07-18 2006-06-01 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Blutflussverbesserer und Mittel zur Vorbeugung oder Heilung von Thrombose
DE60141725D1 (de) 2001-01-19 2010-05-12 Apex Biotechnology Corp Nicht enzymatischer Einwegerkennungselektrodenstreifen der einen oberflächenaktiven Stoff beinhaltet, zum Nachweis von Harnsäure; Herstellungsverfahren dafür und Verwendung davon
CN101851173A (zh) 2001-09-14 2010-10-06 梅特希尔基因公司 组蛋白脱乙酰化酶抑制剂
DK1551793T3 (en) 2002-06-19 2016-04-25 Gnt Pharma Co Ltd Tetrafluorobenzyl derivatives and pharmaceutical compositions containing these for the prevention and treatment of acute and chronic neurodegenerative diseases of the central nervous system
KR100668111B1 (ko) 2005-07-28 2007-01-12 (주)에스에이치제약 강력한 항산화 효과를 가짐으로써 급성 및 퇴행성 뇌신경계질환의 예방 및 치료에 이용 가능한 신규물질인아미노살리실산 유도체와 그 염의 제조방법
US8455470B2 (en) * 2006-04-13 2013-06-04 Neurotech Pharmaceuticals Co., Ltd Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases
CN100422721C (zh) * 2006-05-26 2008-10-01 南京大学 一种利用糖基萘酚的铝离子检测方法
CN102872020A (zh) * 2007-10-23 2013-01-16 株式会社医药分子设计研究所 Pai-1产生抑制剂
KR100852962B1 (ko) 2007-11-12 2008-08-20 주식회사 뉴로테크 2-하이드록시-5-페닐알킬아미노벤조산 유도체 및 이의 염의제조방법
US9085527B2 (en) 2008-07-08 2015-07-21 Catabasis Pharmaceuticals, Inc. Fatty acid acylated salicylates and their uses
ES2656903T3 (es) * 2008-07-08 2018-02-28 Catabasis Pharmaceuticals, Inc. Salicilatos acetilados de ácidos grasos y sus usos
KR101204108B1 (ko) * 2009-02-09 2012-11-22 주식회사 지엔티파마 5-벤질아미노살리실산 유도체 또는 이의 염의 의약 용도
USRE46608E1 (en) 2009-09-01 2017-11-14 Catabasis Pharmaceuticals, Inc. Fatty acid niacin conjugates and their uses
NZ599067A (en) 2009-09-01 2014-04-30 Catabasis Pharmaceuticals Inc Fatty acid niacin conjugates and their uses
CN104603100A (zh) * 2012-05-23 2015-05-06 塞利克斯比奥私人有限公司 用于治疗炎症性肠病的组合物和方法
WO2014070859A1 (en) * 2012-10-30 2014-05-08 H. Lee Moffitt Cancer Center And Research Institute, Inc. Stat3 dimerization inhibitors
EP3902536A4 (en) * 2018-12-28 2022-09-28 GNT Pharma Co., Ltd COMPOSITIONS AND METHODS OF TREATING NEURODEGENERATIVE DISORDERS
CN111116395B (zh) * 2019-12-27 2023-04-07 湖北工业大学 多碘代芳香酸类化合物及其在抗腺病毒7型中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4546M (es) * 1964-06-09 1966-11-02
NL7008623A (es) * 1969-06-25 1970-12-29
JPS5640710B2 (es) * 1973-01-18 1981-09-22
JPS6056130B2 (ja) * 1978-03-20 1985-12-09 久光製薬株式会社 新規なサリチル酸誘導体
US4536346A (en) * 1983-05-06 1985-08-20 American Cyanamid Company Aralkanamidophenyl compounds

Also Published As

Publication number Publication date
JPS62501703A (ja) 1987-07-09
PT81566A (en) 1985-12-01
CN85109554A (zh) 1986-07-23
DK346486D0 (da) 1986-07-21
KR870700608A (ko) 1987-12-30
PT81566B (en) 1987-04-07
ZA859035B (en) 1986-08-27
IT1196348B (it) 1988-11-16
ES8701717A1 (es) 1986-12-01
IT8423799A0 (it) 1984-11-29
GR852834B (es) 1986-03-27
EP0236329A1 (en) 1987-09-16
DK346486A (da) 1986-07-21
AU5231186A (en) 1986-06-18
WO1986003199A1 (en) 1986-06-05

Similar Documents

Publication Publication Date Title
ES549359A0 (es) Un procedimiento para la preparacion de nuevos derivados del acido (5-amino-2-hidroxi)benzoico.
MX156874A (es) Un procedimiento para la preparacion de un diesterasimetrico del acido 1,4-dihidro-2,6-dimetilpiridin-3,5-dicarboxilico
ES552048A0 (es) Un procedimiento para la preparacion de esteres del acido 1,4, dihidro-3,5-piridincarboxilico.
ES518968A0 (es) Un procedimiento para la preparacion de derivados del acido ascorbico.
ES524215A0 (es) Procedimiento para la preparacion de nuevos derivados de acido 2-aza-biciclo(2.2.2)octan-3-carboxilico
ES521337A0 (es) Un procedimiento para la preparacion de derivados del acido fenoxialquilcarboxilico.
ES500253A0 (es) Un procedimiento para la preparacion de nuevos derivados del acido 2-penem-3-carboxilico.
ES521429A0 (es) Un procedimiento para la preparacion de derivados del acido tetrahidrofurancarboxilico.
ES502828A0 (es) Un procedimiento para la preparacion de derivados del acido penen-3-carboxilico.
ES500032A0 (es) Un procedimiento para la preparacion de derivados del acido 7-oxo-1-azabiciclo (3,2,0) hept-2-en-2-carboxilico.
ES545044A0 (es) Un nuevo procedimiento para la preparacion de derivados del acido cicloalquilidenmetilfenilacetico.
ES545565A0 (es) Un procedimiento para la preparacion de derivados del acido fenil nonatetraenoico
ES538906A0 (es) Un procedimiento para la preparacion de nuevos derivados del acido tiazolilacetico.
ES500938A0 (es) Un procedimiento para la preparacion de nuevos derivados del acido acetico.
ES504287A0 (es) Un procedimiento para la preparacion de derivados del acido monico.
ES525238A0 (es) Un procedimiento para la preparacion de derivados del acido penicilanico 6alfa-o-6beta-sustituidos.
ES508346A0 (es) Un procedimiento para la preparacion de derivados del acido 2 beta-clorometil-2 alfa-metilpenam-3 alfa-carboxilico.
ES522620A0 (es) Un procedimiento para la preparacion de derivados de acido 5-oxo-2-pirrolidinpropanoico.
ES502829A0 (es) Un procedimiento para la preparacion de derivados del acido penem-3-carboxilico.
ES539832A0 (es) Procedimiento para la preparacion de un nuevo derivado del acido 5-oxo-2-pirrolidin-carboxilico
ES515577A0 (es) Un procedimiento para la preparacion de nuevos derivados del 1,1-dioxido del acido penicilanico.
ES548977A0 (es) Procedimiento de preparacion de nuevos derivados del acido benzoico
ES504763A0 (es) Un procedimiento para la preparacion de derivados del acido clavolanico.
ES536682A0 (es) Un procedimiento para la preparacion de acido r (2)-4-amino-3-cloro-2-pentenodioico.
ES549165A0 (es) Un procedimiento para la preparacion de derivados del acido ((1,3-dioxo-1,3-propanodiil)diimino-benzoico